Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production

CONCLUSION: This study provides evidence for the beneficial effects of enoxaparin in COVID-19 in addition to its anticoagulant role.PMID:37951516 | DOI:10.1016/j.clim.2023.109836

Source: Clinical Immunology - November 11, 2023 Category: Allergy & Immunology Authors: Emily S C órneo Flavio Protasio Veras Giovanni F Gomes Ayda H Schneider Bruna Manuella Cicero J L R Almeida Camila M Silva Ronaldo B Martins Sabrina S Batah Carla S Simon Gabriele da S Prestes Jos é Carlos Alves-Filho Eurico Arruda Paulo Louzada-Junior Source Type: research